Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
VHAQ.RT was delisted on the 20th of February, 2024.
22 hedge funds and large institutions have $2.55M invested in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
+$338K |
| 2 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$292K |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$268K |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$229K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$187K |
Top Sellers
VHAQ.RT Hedge Fund Activity: Q1 2021 in Review
22 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) for Q1 2021, worth a combined $2.55M.
Buyers outnumbered sellers: 22 funds opened new VHAQ.RT positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Kepos Capital, opening a new position worth an estimated $338K.
- 22 institutional investors held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $2.55M of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock stock for Q1 2021.
- 22 funds opened new Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock positions in Q1 2021 and 0 closed out, a net change of +22 holders.
- The largest Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock buyer in Q1 2021 was Kepos Capital, an estimated $338K added.
Based on aggregated 13F filings for Q1 2021.